These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 1989154)

  • 41. [Cyclosporin in transplantation management--especially after kidney transplantation].
    Quellhorst E
    Internist (Berl); 1996 Jan; 37(1):88-90. PubMed ID: 8837834
    [No Abstract]   [Full Text] [Related]  

  • 42. [Preventing rejection, minimizing toxicity: optimized therapy with cyclosporin].
    MMW Fortschr Med; 2002 Jan; 144(3-4):59. PubMed ID: 11862796
    [No Abstract]   [Full Text] [Related]  

  • 43. Maintenance of unresponsiveness by short-term pulse therapy with FK 506 in rat transplantation.
    Hayakawa K; Hata M; Nishiyama T; Ohashi M; Ishikawa M
    Transplant Proc; 1996 Jun; 28(3):1830-1. PubMed ID: 8658904
    [No Abstract]   [Full Text] [Related]  

  • 44. In vivo immunosuppressive effect of purine nucleoside phosphorylase inhibitor-8-amino-9-benzyl-guanine in canine renal allograft rejection.
    Lin CY; Yen CY
    Transplant Proc; 1994 Dec; 26(6):3126-7. PubMed ID: 7998091
    [No Abstract]   [Full Text] [Related]  

  • 45. The effect of FK778 on acute rat renal allograft rejection and expression of platelet-derived growth factor and transforming growth factor-beta.
    Rintala JM; Savikko J; Rintala SE; von Willebrand E
    Transplant Proc; 2006 Oct; 38(8):2719-21. PubMed ID: 17098049
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Efficacy of leflunomide in combination with current immunosuppressive agents in rat cardiac allotransplantation.
    Candinas D; Achilleos O; Lee SJ; Dalgic A; Mayer AD; Buckels JA; McMaster P; D'Silva M
    Transplant Proc; 1994 Dec; 26(6):3251-2. PubMed ID: 7527959
    [No Abstract]   [Full Text] [Related]  

  • 47. The immunosuppressive agent 15-deoxyspergualin induces tolerance and modulates MHC-antigen expression and interleukin-1 production in the early phase of rat allograft responses.
    Waaga AM; Ulrichs K; Krzymanski M; Treumer J; Hansmann ML; Rommel T; Müller-Ruchholtz W
    Transplant Proc; 1990 Aug; 22(4):1613-4. PubMed ID: 2389421
    [No Abstract]   [Full Text] [Related]  

  • 48. In vivo immunosuppressive effect and the decreasing expression of MHC class II antigens by purine nucleoside phosphorylase inhibitor 8-amino-9-benzylguanine in recipient tissues of canine renal allograft rejection.
    Yen CY; Lin CY
    J Surg Res; 1996 May; 62(2):260-6. PubMed ID: 8632649
    [TBL] [Abstract][Full Text] [Related]  

  • 49. FK778 ameliorates post-transplant expression of fibrogenic growth factors and development of chronic rejection changes in rat kidney allografts.
    Rintala JM; Savikko J; Rintala SE; von Willebrand E
    Nephrol Dial Transplant; 2008 Nov; 23(11):3446-55. PubMed ID: 18558624
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Modification of rat skin allograft rejection by inhibition of thromboxane synthesis.
    Ruiz P; Woodson C; Rey L
    Transplantation; 1992 Aug; 54(2):385-8. PubMed ID: 1496552
    [No Abstract]   [Full Text] [Related]  

  • 51. Comparison of different immunologic modalities on rat limb allotransplantation.
    Hou SM; Liou TC; Chu RM; Yeh LS
    Transplant Proc; 2002 Jun; 34(4):1320-1. PubMed ID: 12072350
    [No Abstract]   [Full Text] [Related]  

  • 52. Effect of short-term administration of deoxyspergualin in rat allogeneic renal transplantation.
    Chikaraishi T; Seki T; Takeuchi I; Tanda K; Kanagawa K; Togashi M; Koyanagi T
    Transplant Proc; 1992 Aug; 24(4):1631-2. PubMed ID: 1496679
    [No Abstract]   [Full Text] [Related]  

  • 53. The behaviour of allogenic skin grafts in gnotobiotically protected rats following administration of an immunosuppressive substance X-100.
    Witek R; Melcer H; Bross W; Kucharczyk W; Kuprowski M; Masiak M; Krupa S
    Folia Biol (Krakow); 1977; 25(2):219-22. PubMed ID: 328320
    [No Abstract]   [Full Text] [Related]  

  • 54. Immunosuppression with melengestrol.
    Kountz SL; Wechter WJ
    Transplant Proc; 1977 Jun; 9(2):1447-53. PubMed ID: 327640
    [No Abstract]   [Full Text] [Related]  

  • 55. Leflunomide (HWA 486), a novel immunomodulating compound for the treatment of autoimmune disorders and reactions leading to transplantation rejection.
    Bartlett RR; Dimitrijevic M; Mattar T; Zielinski T; Germann T; Rüde E; Thoenes GH; Küchle CC; Schorlemmer HU; Bremer E
    Agents Actions; 1991 Jan; 32(1-2):10-21. PubMed ID: 2058454
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effects of sex steroid hormones, estradiol and testosterone on the survival time of skin allografts in rats treated with total body irradiation.
    Hirasawa K
    Transplant Proc; 1992 Aug; 24(4):1567-8. PubMed ID: 1496659
    [No Abstract]   [Full Text] [Related]  

  • 57. Suppression of natural xenophile antibodies with the novel immunomodulating drug leflunomide.
    Ulrichs K; Kaitschick J; Bartlett R; Müller-Ruchholtz W
    Transplant Proc; 1992 Apr; 24(2):718-9. PubMed ID: 1566498
    [No Abstract]   [Full Text] [Related]  

  • 58. Malononitrilamides prevent the generation of oxygen radicals in mononuclear phagocytes and graft rejection in a rat model.
    Schorlemmer HU; Bartlett RR; Kurrle R
    Transplant Proc; 1999; 31(1-2):851-3. PubMed ID: 10083371
    [No Abstract]   [Full Text] [Related]  

  • 59. Pulse therapy for rejection with deoxyspergualin in renal recipients: a multicenter controlled study.
    Amemiya H; Ota K; Sonoda T; Fukao K; Taguchi Y; Isono K; Omoto R; Takagi H; Oka T; Orita K
    Transplant Proc; 1992 Aug; 24(4):1375-6. PubMed ID: 1496591
    [No Abstract]   [Full Text] [Related]  

  • 60. Immunosuppressive effects of cyclophosphamide and L-asparaginase in the inbred rat renal transplant model.
    Levin B; Merrill JP
    Transplantation; 1972 Feb; 13(2):160-3. PubMed ID: 4550990
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.